SCIENTIFIC PROGRAM

2nd Familial Mediterranean
Fever Meeting

FMF 2024

Program

May 3, 2024 (Friday)
GMT + 3
16.00-18.00 Session 1 – Old paradigms, new concepts Chairpersons: Hasan Yazıcı (Türkiye),
Isabelle Touitou (France)
16.00-16.20 Unmet needs in FMF Huri Özdoğan (Türkiye)
16.20-16.50 Old paradigms and new concepts in FMF Eldad Ben-Chetrit (Israel)
16.50-17.20 What is FMF? Ahmet Gül (Türkiye)
17.20-17.50 Review of the last two year Yelda Bilginer (Türkiye)
19.00 Welcome Reception
May 4, 2024 (Saturday)
GMT + 3
08.00 – 10.00 Session 2 – Update: Genetics and Pathogenesis Chairpersons: Ahmet Gül (Türkiye),
Tillmann Kallinich (Germany),
Banu Peynircioğlu (Türkiye)
08.00-08.30 The changing concept of one gene-one phenotype in monogenic autoinflammatory diseases Ivona Aksentijevich (USA)
08.30-09.00 Regulation of pyrin inflammasome Mohamed Lamkanfi (Belgium)
09.00-09.20 Pyroptosis and clinical implications in FMF Helmut Wittkowski (Germany)
09.20-09.40 Pyrin inflammasome and inflammatory cell migration in FMF Tayfun Hilmi Akbaba (Türkiye)
09.40-10.00 Discussion
10.00-10.30 Coffee Break
10.30-12.00 Session 3 – Update: Genetic diagnosis, environmental factors and microbiome Chairpersons: Seza Özen(Türkiye),
Dorota Rowczenio (UK)
10.30-11.00 Update: genetic diagnosis in FMF Isabelle Touitou (France)
11.00-11.20 Non-MEFV gen variants in patients with a FMF phenotype Eda Tahir Turanlı (Türkiye)
11.20-11.40 Syndrome of Undifferentiated Recurrent Fever (SURF) Marco Gattorno (Italy)
11.40-12.00 Impact of enviromental factors and microbiome on the pathogenesis of FMF Sophie Georgin Lavialle (France)
12.00-12.30 Oral presentations Chairpersons: Fatoş Önen (Türkiye),
Ömer Karadağ (Türkiye)
12.00-12.07 A clinical overview of unclassified systemic autoinflammatory diseases followed in a Turkish Pediatric Referral Center (Ref: 115) Şengül Çağlayan (Türkiye)
12.07-12.14 Evaluation of patients carrying variants of unknown significance (VUS) in a large FMF cohort: A single center study (Ref: 116)  Taner Coşkuner (Türkiye)
12.14-12.21 Exploring S100A8/A9, Neopterin, and MMP3 in Familial Mediterranean Fever: Insights into pathogenesis and diagnostic significance (Ref: 145) Özgür Can Kılınc (Türkiye)
12.21-12.28 Epidemiological features and clinical manifestations in lebanese and Italian subjects with Familial Mediterranean Fever (Ref: 130) Nour Jaber (Italy)
12.30-13.30 Lunch & Poster Reviewing
13.30-15.30 Session 4 – Criteria, registry, geography Chairpersons: Helmut Wittkowski (Germany),
Fatoş Yalçınkaya (Türkiye)
13.30-13.50 Pros and cons of diagnostic and classification criteria for FMF Isabelle Kone-Paut (France)
13.50-14.10 Challenges of preparing a registry for FMF Marco Gattorno (Italy)
14.10-14.20 Discussion
14.20-15.30 Round Table: FMF around the world  Chairpersons: Seza Özen (Türkiye),
Huri Özdoğan (Türkiye),
Eldad Ben-Chetrit (Israel)
14.20-14.35 FMF in Japan Tomohiro Koga (Japan)
14.35-14.50 FMF in Italy Raffaele Manna (Italy)
14.50-15.05 FMF in Saudi Arabia Sulaiman Al-Mayouf (Saudi Arabia)
15.05-15.30 Discussion
15.30-16.00 Coffee Break 
16.00-17.40 Session 5 – Update: Amyloidosis, associated diseases Helen Lachmann (UK),
Cengiz Korkmaz (Türkiye),
Melike Melikoğlu (Türkiye)
16.00-16.20 Is amyloidosis still a threat in FMF? Ahmet Gül (Türkiye)
16.20-16.40 Early versus late onset FMF Piero Portincasa (Italy)
16.40-17.00 PFAPA and FMF Özgür Kasapçopur (Türkiye)
17:00-17.20 AS and enthesitis in FMF Servet Akar (Türkiye)
17.20-17.40 Behçet’s disease and FMF Emire Seyahi (Türkiye)
17.40-18.08 Oral presentations Chairpersons: Mikail Kostik (Russia),
Hakan Babaoğlu (Türkiye)
17.40-17.47 Gender differences in the diagnosis delay of familial Mediterranean fever: A JIR cohort study (Ref: 91) Rim Bourguiba (Tunisia)
17.47-17.54 Cardiovascular comorbidities in patients with Familial Mediterranean Fever over 45 years of age (Ref: 133) Sejla Karup (Türkiye)
17.54-18.01 Male fertility and paternal effect on pregnancy outcomes in FMF (Ref: 150) Kerem Parlar (Türkiye)
18.01-18.08 Menstrual cycle patterns and dysmenorrhea frequency in adolescent girls with familial Mediterranean fever: Cross-Sectional case-control study (Ref: 106) Fatma Gül Demirkan (Türkiye)
May 5, 2024 (Sunday)
GMT + 3
08.00-10.00 Session 6a. – Upate:Treatment-I Chairpersons: Huri Özdoğan(Türkiye),
Sophie Georgin-Lavialle (France),
Serdal Uğurlu (Türkiye)
08.00-08.20 Mechanism of action of colchicine and its expanding efficacy Eldad Ben-Chetrit (Israel)
08.20-08.40 Colchicine response and tolerance in FMF Seza Özen (Türkiye)
08.40-09.00 Anti-IL1 treatment in FMF Serdal Uğurlu (Türkiye)
09.00-09.15 On-demand anti-IL1 treatment Ilan Ben-Zvi (Israel)
09.15-09.40 Efficacy and safety of anti-IL1β treatment in FMF Helen Lachmann (UK)
09.40-10.00 Anti-IL6 treatment FMF Tomohiro Koga (Japan)
10.00-10.30 Coffee Break 
10.30-12.30 Session 6b. – Update: Treatment II Chairpersons: Ahmet Gül(Türkiye),
Isabelle Kone-Paut (France)
10.30-10.50 Biologic agent combinations in the management of FMF and other autoinflammatory diseases Abdurrahman Tufan (Türkiye)
10.50-11.10 Treat-to target strategies in FMF Tillmann Kallinich (Germany)
11.10-11.40 Discussion for sessions 6a and 6b
11.40-12.30 Session 7 – Transition Chairpersons:  Kenan Barut (Türkiye),
Gülay Özgön(Türkiye),
Amra Adrovich (Türkiye)
11.40-12.00 Transition from pediatric to adult FMF clinics Betül Sözeri (Türkiye)
12.00-12.42 Oral presentations
12.00-12.07 Machine learning algorithms to predict colchicine resistance in Familial Mediterranean Fever (Ref: 158) Admir Öztürk (Türkiye)
12.07-12.14 Comparing the effects of treatments during the attack period on clinical and laboratory data in Familial Mediterranean Fever Patients (Ref: 143) Elif Kılıç Konte (Türkiye)
12.14-12.21 Familial Mediterranean Fever: Effective follow-up of patients who ceased colchicine treatment (Ref: 122) Gülcan Özomay Baykal (Türkiye)
12.21-12.28 Canakinumab treatment in patients with colchicine-resistant familial Mediterranean fever: a multicenter observational study (Ref: 83) Mete Kara (Türkiye)
12.28-12.35 Is canakinumab a good tool for the undifferentiated autoinflammatory diseases: the data of retrospective cohort study (Ref: 108) Mikhail Kostik (Russia)
12.35-12.42 Familial Mediterranean Fever from childhood to adulthood (Ref: 163) Zeynep Balık (Türkiye)
12.42-12.50 Discussion
12.50-13.10 Highlights of the meeting Sezgin Şahin (Türkiye)
13.10-13.30 Future perspectives, presentation of awards, closing remarks Huri Özdoğan (Türkiye),
Eldad Ben-Chetrit (Israel),
Serdal Uğurlu (Türkiye)
image_pdf


D Event Tourism Organization
Professional Congress Organizer (PCO)
İçerenköy Mah. Çayır Cad. No:5 Bay Plaza Kat:12
Ataşehir, İstanbul
Phone: +90 216 573 18 36
Web: www.devent.com.tr
e-mail: istanbul1@devent.com.tr

D Event Tourism Organization